GRI Bio Inc (NAS:GRI) Stock News, Headlines & Updates
GRI Bio Inc Stock News from GuruFocus
- 1
Jul 02, 2024
GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine
Marketwired • 9:00am
Jul 01, 2024
GRI Bio to Present at the 8th Annual IPF Summit
Marketwired • 8:00am
Jun 28, 2024
GRI Bio Announces Closing of $4.0 Million Public Offering
Marketwired • 4:00pm
Jun 27, 2024
GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
Marketwired • 8:00am
GRI Bio Announces Pricing of $4 Million Public Offering
Marketwired • 7:00am
Jun 14, 2024
GRI Bio Announces Reverse Stock Split
Marketwired • 8:00am
Jun 11, 2024
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
Marketwired • 8:00am
May 21, 2024
GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)
Marketwired • 8:00am
May 20, 2024
GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
Marketwired • 8:00am
May 14, 2024
GRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
Marketwired • 9:00am
May 13, 2024
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Marketwired • 7:00am
Apr 29, 2024
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
Marketwired • 8:00am
Apr 25, 2024
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Marketwired • 9:00am
Apr 16, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news